menu
    • menu

    All Manufacturers, Suppliers, Distributors and Exporters of Alteplase with approved in Europe Marketing Authorisations (MA) of Finished Dosage Form listed on PharmaCompass.com

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    0

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    3

    NDC API

    NDC API

    0

    VMF

    NDC API

    0

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 0

    MARKET PLACE

    4

    API

    3

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    24

    FDF Dossiers

    FDF Dossiers

    3

    FDA Orange Book

    FDA (Orange Book)

    17

    Europe

    Europe

    3

    Canada

    Canada

    0

    Australia

    Australia

    1

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    2DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    4

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    8,211

    Finished Drug Prices

    NA

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 177799-16-5, Ttpa, 9,10-bis[n,n-di(p-tolyl)amino]anthracene, 9-n,9-n,10-n,10-n-tetrakis(4-methylphenyl)anthracene-9,10-diamine, N9,n9,n10,n10-tetra-p-tolylanthracene-9,10-diamine, Schembl1261345
    Molecular Formula
    C42H36N2
    Molecular Weight
    568.7  g/mol
    InChI Key
    FWXNJWAXBVMBGL-UHFFFAOYSA-N
    Alteplase
    A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases.
    1 2D Structure

    Alteplase

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    9-N,9-N,10-N,10-N-tetrakis(4-methylphenyl)anthracene-9,10-diamine
    2.1.2 InChI
    InChI=1S/C42H36N2/c1-29-13-21-33(22-14-29)43(34-23-15-30(2)16-24-34)41-37-9-5-7-11-39(37)42(40-12-8-6-10-38(40)41)44(35-25-17-31(3)18-26-35)36-27-19-32(4)20-28-36/h5-28H,1-4H3
    2.1.3 InChI Key
    FWXNJWAXBVMBGL-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1=CC=C(C=C1)N(C2=CC=C(C=C2)C)C3=C4C=CC=CC4=C(C5=CC=CC=C53)N(C6=CC=C(C=C6)C)C7=CC=C(C=C7)C
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. Actilyse

    2. Activase

    3. Alteplase

    4. Lysatec Rt Pa

    5. Lysatec Rt-pa

    6. Lysatec Rtpa

    7. Plasminogen Activator, Tissue

    8. Plasminogen Activator, Tissue Type

    9. Plasminogen Activator, Tissue-type

    10. T Plasminogen Activator

    11. T-plasminogen Activator

    12. Tisokinase

    13. Tissue Activator D 44

    14. Tissue Activator D-44

    15. Tissue Plasminogen Activator

    16. Tissue Type Plasminogen Activator

    17. Tissue-type Plasminogen Activator

    18. Ttpa

    2.2.2 Depositor-Supplied Synonyms

    1. 177799-16-5

    2. Ttpa

    3. 9,10-bis[n,n-di(p-tolyl)amino]anthracene

    4. 9-n,9-n,10-n,10-n-tetrakis(4-methylphenyl)anthracene-9,10-diamine

    5. N9,n9,n10,n10-tetra-p-tolylanthracene-9,10-diamine

    6. Schembl1261345

    7. Dtxsid30629288

    8. Cha79916

    9. 9,10-anthracenediamine, N9,n9,n10,n10-tetrakis(4-methylphenyl)-

    10. Mfcd12022465

    11. Akos027252460

    12. As-71559

    13. 9,10-bis[n,n-di(p-tolyl)amino]anthracene, 98%

    14. N,n,n',n'-tetrakis(p-tolyl)anthracene-9,10-diamine

    15. N,n,n',n'-tetrakis(4-methylphenyl)-9,10-anthracenediamine

    16. N~9~,n~9~,n~10~,n~10~-tetrakis(4-methylphenyl)anthracene-9,10-diamine

    17. N9,n9,n10,n10-tetrakis(4-methylphenyl)anthracene-9,10-diamine

    2.3 Create Date
    2007-12-05
    3 Chemical and Physical Properties
    Molecular Weight 568.7 g/mol
    Molecular Formula C42H36N2
    XLogP312.4
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count6
    Exact Mass568.287849157 g/mol
    Monoisotopic Mass568.287849157 g/mol
    Topological Polar Surface Area6.5 Ų
    Heavy Atom Count44
    Formal Charge0
    Complexity728
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Fibrinolytic Agents

    Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search